Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The company returns high margins, thereby supporting business profitability.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Its low valuation, with P/E ratio at 7.64 and 6 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.